RESUMEN
BACKGROUND: Tourette syndrome (TS) is a complex neuropsychiatric disorder coupled with obvious genetic heterogeneity. Studies in recent years have confirmed the association of SLITRK genes with sensory and neuropsychiatric diseases. To detect whether SLITRK6 is involved in the progress of TS, a family-based association study was performed to explore the possible genetic association between SLITRK6 and TS in the Chinese Han population. METHODS: We genotyped 399 TS nuclear families trios, and then analyzed three tag SLITRK6 single nucleotide polymorphisms using the transmission disequilibrium test (TDT) haplotype relative risk (HRR) and haplotype-based haplotype relative risk (HHRR) methods. RESULTS: The TDT showed no statistically significant allele transfer for the three polymorphisms. The HRR and HHRR also showed a negative association. CONCLUSIONS: Despite the results suggesting that these polymorphisms may not be associated with susceptibility to TS in the Chinese Han population, we are still unable to determine the potential role of SLITRK6 in the pathogenesis of TS. Furthermore, the results still need to be confirmed in a larger sample size and in different populations.
Asunto(s)
Predisposición Genética a la Enfermedad , Proteínas de la Membrana/genética , Polimorfismo de Nucleótido Simple , Síndrome de Tourette/etiología , Adolescente , Alelos , Pueblo Asiatico/genética , Niño , Preescolar , China , Femenino , Frecuencia de los Genes , Estudios de Asociación Genética , Genotipo , Haplotipos , Humanos , Desequilibrio de Ligamiento , Masculino , Proteínas de la Membrana/metabolismo , Medición de Riesgo , Síndrome de Tourette/diagnósticoRESUMEN
Preeclampsia (PE) is a major obstetrical complication that results in maternal and fetal morbidity and mortality. Aberrant epigenetic modifications are widely involved in the pathogenesis of PE. Previously, the activated leukocyte cell adhesion molecule (ALCAM) was reported to be required for blastocyst implantation but has not been described in the context of pathological pregnancy. This study explored the expression of ALCAM and its methylation levels in the placentas and peripheral venous blood of patients with PE from a Chinese Han population. The mRNA and protein expression levels of ALCAM were downregulated in the PE placentas compared with the control placentas (P < 0.05). The methylation rate of the ALCAM gene promoter was considerably elevated in the placentas (P = 0.003, odds ratio (OR) = 0.264, 95% confidence interval (95% CI) [0.108-0.647], cases n = 47, controls n = 53) and peripheral blood (P = 0.007, OR = 0.455, 95% CI [0.256-0.806], cases n = 100, controls n = 100) of the PE patients compared with those of the normotensive women, suggesting a negative relationship between ALCAM methylation and gene transcription. Moreover, the transcriptional expression of ALCAM was dramatically increased by demethylating treatment in trophoblastic cells. ALCAM is expected to be involved in the pathogenesis of PE through methylation regulation.
Asunto(s)
Antígenos CD/metabolismo , Moléculas de Adhesión Celular Neuronal/metabolismo , Metilación de ADN , Proteínas Fetales/metabolismo , Placenta/metabolismo , Preeclampsia/metabolismo , Regiones Promotoras Genéticas , Adulto , Antígenos CD/genética , Estudios de Casos y Controles , Moléculas de Adhesión Celular Neuronal/genética , Femenino , Proteínas Fetales/genética , Humanos , Preeclampsia/genética , Embarazo , Trofoblastos/metabolismoRESUMEN
Accumulating evidence has suggested that microRNAs play important roles in the development of hepatocellular carcinoma (HCC) and are involved in drug resistance. miR-21-5p was overexpressed in a variety of cancers and promoted the tumorigenesis; however, the function of miR-21-5p in HCC still remains unknown. In this study, our results showed that miR-21-5p was highly expressed in HCC tissues and cell lines. Notably, the level of miR-21-5p was relatively higher in cisplatin (DDP)-resistant HCC patients. Overexpression of miR-21-5p attenuated the inhibitory effect of DDP on the proliferation and apoptosis of HCC cells. Mechanistically, the luciferase report assay-identified FAS ligand (FASLG) was a direct target of miR-21-5p. Overexpression of miR-21-5p decreased both the mRNA and protein levels of FASLG in HCC cells. FASLG was downregulated in HCC tissues and was significantly negatively correlated with the expression of miR-21-5p. Restoring the expression of FASLG upregulated the chemosensitivity of HCC cells expressing miR-21-5p. In conclusion, our results demonstrated that miR-21-5p targeted FASLG and suppressed the sensitivity of HCC cells to DDP treatment.
Asunto(s)
Carcinoma Hepatocelular/tratamiento farmacológico , Cisplatino/farmacología , Proteína Ligando Fas/genética , Neoplasias Hepáticas/tratamiento farmacológico , MicroARNs/genética , Anciano , Animales , Antineoplásicos/farmacología , Carcinoma Hepatocelular/genética , Carcinoma Hepatocelular/mortalidad , Supervivencia sin Enfermedad , Resistencia a Antineoplásicos/genética , Proteína Ligando Fas/metabolismo , Femenino , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Humanos , Neoplasias Hepáticas/genética , Neoplasias Hepáticas/mortalidad , Masculino , Ratones Endogámicos BALB C , Persona de Mediana Edad , Ensayos Antitumor por Modelo de XenoinjertoRESUMEN
Non-small-cell lung cancer (NSCLC) is the most common type in lung cancer, a leading cause of cancer-related death worldwide. Our previous study unraveled a pro-cancer function of IL-33 in fueling outgrowth and metastasis of human NSCLC cells. Herein, we determined that interfere with IL-33 activity was an effective strategy for limiting NSCLC tumor growth using a preclinical model with human NSCLC xenografts. IL-33 blockade efficiently inhibited tumor growth of NSCLC xenografts in immune-deficient mice. Mechanistically, IL-33 blockade suppressed outgrowth capacity of human NSCLC cells. Meanwhile, IL-33 blockade abrogated polarization of M2 tumor-associated macrophages (TAMs) and reduced accumulation of regulatory T cells (Tregs) in tumor microenvironments, shaping functional immune surveillance. In NSCLC patients, IL-33 expressions were positively correlated with Ki-67 proliferation index and expressions of M2 TAM- and Teg-related genes. These findings identify IL-33 as a dual-functional factor in NSCLC pathogenesis and suggest IL-33 blockade as a promising therapeutic for NSCLC patients.
RESUMEN
This study was designed to prepare the artificial fiber complexes and examine its role in lipid peroxidation in comparison with other fibers. Sixty-four healthy, female Wistar rats (50-80 g) were randomly divided into eight groups based on body weight. All seven kinds of DF (cellulose--group B, pectin--group C, sodium alginate--group D, cellulose-pectin complex--group E, cellulose-sodium alginate complex--group F, cellulose-pectin mixture--group G, cellulose-sodium alginate mixture--group H) were given at a level of 10% in the diet fed on a lipid-rich diet. The control group (group A) was fed on a lipid-rich diet alone without DF. After eight weeks, the effect on growth and development, lipid metabolism and lipid peroxidation in rats were studied. The results showed that: 1. Seven kinds of DF did not affect the growth and development of the experimental rats. 2. Seven kinds of DF all can increase serum superoxide dismutase (SOD) and glutathione peroxidase (GsH-Px) activities and reduce malondiadehyde (MDA) content (except group B and D). Erythrocyte membrane fluidity was significantly increased in DF groups, and fiber complex groups were most effective. 3. The fecal weight and fat contents in all DF groups were significantly higher than that in control group, especially for fiber mixture and complex groups. It is concluded that all these kinds of DF have the effect of reducing lipid peroxidation to some extent in rats, and fiber complexes might be the most effective.